Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager

Nykode Therapeutics ASA

OSE:NYKD

Watchlist

Dividends

Price: 2.168 NOK 1.59% Market Closed

Market Cap: 708m NOK

Have any thoughts about
Nykode Therapeutics ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 2.168 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NYKD Alert

Nykode Therapeutics ASA

2.168

+0.034 (+1.59%)

52 Week Range	2.134 21.4
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Nykode Therapeutics ASA

What unique competitive advantages
does Nykode Therapeutics ASA hold over its rivals?

What risks and challenges
does Nykode Therapeutics ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Nykode Therapeutics ASA.

What unique competitive advantages
does Nykode Therapeutics ASA hold over its rivals?

What risks and challenges
does Nykode Therapeutics ASA face in the near future?

Summarize the latest earnings call
of Nykode Therapeutics ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nykode Therapeutics ASA.

Provide P/S
for Nykode Therapeutics ASA.

Provide P/E
for Nykode Therapeutics ASA.

Provide P/OCF
for Nykode Therapeutics ASA.

Provide P/FCFE
for Nykode Therapeutics ASA.

Provide P/B
for Nykode Therapeutics ASA.

Provide EV/S
for Nykode Therapeutics ASA.

Provide EV/GP
for Nykode Therapeutics ASA.

Provide EV/EBITDA
for Nykode Therapeutics ASA.

Provide EV/EBIT
for Nykode Therapeutics ASA.

Provide EV/OCF
for Nykode Therapeutics ASA.

Provide EV/FCFF
for Nykode Therapeutics ASA.

Provide EV/IC
for Nykode Therapeutics ASA.

Show me price targets
for Nykode Therapeutics ASA made by professional analysts.

What are the Revenue projections
for Nykode Therapeutics ASA?

How accurate were the past Revenue estimates
for Nykode Therapeutics ASA?

What are the Net Income projections
for Nykode Therapeutics ASA?

How accurate were the past Net Income estimates
for Nykode Therapeutics ASA?

What are the EPS projections
for Nykode Therapeutics ASA?

How accurate were the past EPS estimates
for Nykode Therapeutics ASA?

What are the EBIT projections
for Nykode Therapeutics ASA?

How accurate were the past EBIT estimates
for Nykode Therapeutics ASA?

Compare the revenue forecasts
for Nykode Therapeutics ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nykode Therapeutics ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nykode Therapeutics ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nykode Therapeutics ASA compared to its peers.

Compare the P/E ratios
of Nykode Therapeutics ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Nykode Therapeutics ASA with its peers.

Analyze the financial leverage
of Nykode Therapeutics ASA compared to its main competitors.

Show all profitability ratios
for Nykode Therapeutics ASA.

Provide ROE
for Nykode Therapeutics ASA.

Provide ROA
for Nykode Therapeutics ASA.

Provide ROIC
for Nykode Therapeutics ASA.

Provide ROCE
for Nykode Therapeutics ASA.

Provide Gross Margin
for Nykode Therapeutics ASA.

Provide Operating Margin
for Nykode Therapeutics ASA.

Provide Net Margin
for Nykode Therapeutics ASA.

Provide FCF Margin
for Nykode Therapeutics ASA.

Show all solvency ratios
for Nykode Therapeutics ASA.

Provide D/E Ratio
for Nykode Therapeutics ASA.

Provide D/A Ratio
for Nykode Therapeutics ASA.

Provide Interest Coverage Ratio
for Nykode Therapeutics ASA.

Provide Altman Z-Score Ratio
for Nykode Therapeutics ASA.

Provide Quick Ratio
for Nykode Therapeutics ASA.

Provide Current Ratio
for Nykode Therapeutics ASA.

Provide Cash Ratio
for Nykode Therapeutics ASA.

What is the historical Revenue growth
over the last 5 years for Nykode Therapeutics ASA?

What is the historical Net Income growth
over the last 5 years for Nykode Therapeutics ASA?

What is the current Free Cash Flow
of Nykode Therapeutics ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nykode Therapeutics ASA.

NYKD

Balance Sheet

Cash Equivalents

Nykode Therapeutics ASA
Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Nykode Therapeutics ASA
Cash Equivalents Peer Comparison

Comparables:

HBC

BGBIO

LYTIX

AZT

TRMED

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company		Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
N	Nykode Therapeutics ASA OSE:NYKD	Cash Equivalents $136.5m	CAGR 3-Years -8%	CAGR 5-Years 29%	CAGR 10-Years N/A
	Hofseth Biocare ASA OSE:HBC	Cash Equivalents kr25.3m	CAGR 3-Years -39%	CAGR 5-Years 5%	CAGR 10-Years 20%
B	Bergenbio ASA OSE:BGBIO	Cash Equivalents kr200.1m	CAGR 3-Years -30%	CAGR 5-Years -9%	CAGR 10-Years N/A
L	Lytix Biopharma AS OSE:LYTIX	Cash Equivalents kr27.4m	CAGR 3-Years -1%	CAGR 5-Years -11%	CAGR 10-Years N/A
	Arcticzymes Technologies ASA OSE:AZT	Cash Equivalents kr170.3m	CAGR 3-Years -1%	CAGR 5-Years 51%	CAGR 10-Years 7%
T	Thor Medical ASA OSE:TRMED	Cash Equivalents kr29.6m	CAGR 3-Years -60%	CAGR 5-Years -42%	CAGR 10-Years -5%

What is Nykode Therapeutics ASA's Cash Equivalents?

Cash Equivalents
136.5m USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's Cash Equivalents amounts to 136.5m USD.

What is Nykode Therapeutics ASA's Cash Equivalents growth rate?

Cash Equivalents CAGR 5Y
29%

Over the last year, the Cash Equivalents growth was -21%. The average annual Cash Equivalents growth rates for Nykode Therapeutics ASA have been -8% over the past three years , 29% over the past five years .

Nykode Therapeutics ASA
OSE:NYKD

Nykode Therapeutics ASA
Cash Equivalents

Nykode Therapeutics ASA
Cash Equivalents Peer Comparison

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

See Also

What is Nykode Therapeutics ASA's Cash Equivalents?

Cash Equivalents
136.5m USD

What is Nykode Therapeutics ASA's Cash Equivalents growth rate?

Cash Equivalents CAGR 5Y
29%

Company

Help

Tools

Stocks

Nykode Therapeutics ASA OSE:NYKD

Nykode Therapeutics ASA Cash Equivalents

Nykode Therapeutics ASA Cash Equivalents Peer Comparison

Competitive Cash Equivalents Analysis Latest Figures & CAGR of Competitors

See Also

What is Nykode Therapeutics ASA's Cash Equivalents? Cash Equivalents 136.5m USD

What is Nykode Therapeutics ASA's Cash Equivalents growth rate? Cash Equivalents CAGR 5Y 29%

Company

Help

Tools

Stocks

Nykode Therapeutics ASA
OSE:NYKD

Nykode Therapeutics ASA
Cash Equivalents

Nykode Therapeutics ASA
Cash Equivalents Peer Comparison

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

What is Nykode Therapeutics ASA's Cash Equivalents?

Cash Equivalents
136.5m USD

What is Nykode Therapeutics ASA's Cash Equivalents growth rate?

Cash Equivalents CAGR 5Y
29%